RXRX offering history
Every offering-related filing in RECURSION PHARMACEUTICALS, INC.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 963 filings back to Apr 2, 2014.
| Date | Filing | What it means | |
|---|---|---|---|
| Feb 25, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 26, 2025 | 424B7 → | UPDATE | Resale prospectus — existing holders registering to sell |
| Aug 29, 2025 | 424B7 → | UPDATE | Resale prospectus — existing holders registering to sell |
| Jul 8, 2025 | 424B7 → | UPDATE | Resale prospectus — existing holders registering to sell |
| Jul 8, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 9, 2025 | 424B7 → | UPDATE | Resale prospectus — existing holders registering to sell |
| Feb 28, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 12, 2025 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Dec 17, 2024 | 424B7 → | UPDATE | Resale prospectus — existing holders registering to sell |
| Aug 8, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 27, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 26, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 15, 2023 | 424B7 → | UPDATE | Resale prospectus — existing holders registering to sell |
| Nov 9, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 8, 2023 | 424B7 → | UPDATE | Resale prospectus — existing holders registering to sell |
| Aug 8, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 12, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 9, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 30, 2023 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| May 8, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 28, 2022 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Oct 25, 2022 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 10, 2022 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Apr 16, 2021 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Apr 15, 2021 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 15, 2021 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Apr 15, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 12, 2021 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Mar 22, 2021 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
RXRX offering FAQ
When did RXRX last execute an offering?
Per SEC filings, RECURSION PHARMACEUTICALS, INC.'s most recent priced offering document is a 424B5 filed 2026-02-25. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did RXRX last announce or register an offering?
The most recent registration is a S-3ASR filed 2025-02-12. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.